Circulating miRNAs act as potential biomarkers for asthma

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Biomarker Discovery

Background:

• Asthma pathogenesis understanding benefits from new clinical markers.
• LIGHT is a crucial factor in asthma and a potential therapeutic target.
• Investigating circulating microRNAs (miRNAs) targeting LIGHT for diagnostic potential in asthma.

Purpose of the Study:

• To determine if circulating miRNAs targeting LIGHT can serve as diagnostic biomarkers for asthma.
• To assess the diagnostic efficacy of specific miRNAs in distinguishing asthma patients from healthy individuals.

Main Methods:

• Serum samples from 60 subjects (20 mild asthma, 20 moderate-to-severe asthma, 20 healthy controls) were analyzed.
• Circulating miRNA profiles were assessed using miRNA microarray and verified with Real Time PCR.
• Correlations between miRNAs targeting LIGHT and clinical characteristics were investigated.

Main Results:

• 365 miRNAs were differentially expressed in asthma patients.
• miR-107 and miR-140-5p were identified as LIGHT-targeting miRNAs with varying expression in asthmatics.
• miR-140-5p and miR-107 demonstrated good diagnostic efficacy for asthma (AUC=0.8667 and 0.9400, respectively).

Conclusions:

• Plasma miR-140-5p and miR-107 are potential diagnostic biomarkers for distinguishing asthma patients from healthy controls.
• These miRNAs may contribute to asthma pathogenesis by negatively regulating LIGHT.
• Further research is warranted to evaluate their role as asthma diagnostic biomarkers.